Company intelligence / Profile preview

BioKier, Inc.

Chapel Hill, North Carolina, United Statesbiokier.com ↗

Ownership: Private
Employees: ~4
Development stage: Phase 2

Overview

BioKier has completed clinical trials showing their approach improves gut hormone secretion and regulation of glucose and lipids. Currently conducting Phase 1/2 trials for their lead product BKR-017.

Therapeutic areas: EndocrinologyCardiovascular
Modalities: Small molecule drugOral products
Industry: Biotech

Drug pipeline

3 assets

BKR-017

2 more assets in the full pipeline.

Request access →

Partnerships

Mayo Clinic

Beyond the preview

Go deeper on BioKier, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioKier, Inc..

Explore the full profile